Clinical Trials Browser

INDUSTRY × Interventional × Chemotherapy-induced Peripheral Neuropathy × Clear all

NCT05251727 2024-08-19

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Phase 1 Terminated

Chemotherapy-induced Peripheral Neuropathy

NCT05593614 2024-07-16

ACT

Phase 2 Active not recruiting

Chemotherapy-induced Peripheral Neuropathy

NCT04282590 2022-03-15

A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

Phase 2 Withdrawn

Chemotherapy-induced Peripheral Neuropathy